Griscelli syndrome
Griscelli syndrome is a rare genetic disorder characterized by a distinctive silver-gray hair, immunodeficiency, and neurological abnormalities. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder.
Classification[edit | edit source]
Griscelli syndrome is classified into three types based on the specific gene mutations and the clinical manifestations:
- Type 1 (GS1) is caused by mutations in the MYO5A gene and is primarily associated with severe neurological impairment.
- Type 2 (GS2) results from mutations in the RAB27A gene and is characterized by immunodeficiency and an increased risk of developing hemophagocytic lymphohistiocytosis (HLH).
- Type 3 (GS3) is due to mutations in the MLPH gene and typically presents with milder symptoms, primarily affecting the skin and hair.
Symptoms[edit | edit source]
The symptoms of Griscelli syndrome can vary depending on the type but generally include:
- Silver-gray hair with large clumps of pigment in the hair shaft
- Light skin pigmentation
- Recurrent infections due to immunodeficiency (particularly in GS2)
- Neurological abnormalities such as developmental delay, hypotonia, and seizures (particularly in GS1)
- Hemophagocytic lymphohistiocytosis (HLH) in GS2, which is a severe, life-threatening condition
Diagnosis[edit | edit source]
Diagnosis of Griscelli syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the MYO5A, RAB27A, or MLPH genes. Microscopic examination of hair samples can reveal characteristic pigment clumps.
Treatment[edit | edit source]
There is no cure for Griscelli syndrome, and treatment is primarily supportive and symptomatic. Management may include:
- Antibiotics and antifungal medications to treat infections
- Immunosuppressive therapy for HLH
- Physical therapy and other supportive measures for neurological symptoms
- Bone marrow transplantation may be considered in severe cases, particularly for GS2 with HLH
Prognosis[edit | edit source]
The prognosis for individuals with Griscelli syndrome varies depending on the type and severity of symptoms. GS1 and GS2 are generally associated with a poorer prognosis due to severe neurological impairment and life-threatening HLH, respectively. GS3 typically has a better prognosis with milder symptoms.
Related Pages[edit | edit source]
- Autosomal recessive disorder
- Immunodeficiency
- Neurological disorder
- Hemophagocytic lymphohistiocytosis
- Genetic testing
Categories[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD